New York Life Investment Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

New York Life Investment Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24,061	Closed	-$378K	–	1367
2024 Q1	$378K	Buy	24,061 +1,535	+7%	+$23.6K	﹤0.01%	857
2023 Q4	$363K	Sell	22,526 -519	-2%	-$6.62K	﹤0.01%	1086
2023 Q3	$293K	Sell	23,045 -3,630	-14%	-$50.1K	﹤0.01%	1169
2023 Q2	$376K	Sell	26,675 -3,902	-13%	-$55.8K	﹤0.01%	1088
2023 Q1	$472K	Buy	+30,577	New	+$511K	0.01%	1047

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

New York Life Investment Management's DCPH Position: Q2 2024 in Review

New York Life Investment Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 24,061 shares — an estimated $378K sold.

New York Life Investment Management first reported a position in DCPH in Q1 2023 and held it in 5 quarters. The position peaked at $472K in Q1 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

New York Life Investment Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
New York Life Investment Management sold 24,061 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $378K.
New York Life Investment Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
New York Life Investment Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $472K in Q1 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.